Skip to main content

Digital Biomarkers Market - Increasing Cost of Drug Development to Boost Its Growth

 

Digital biomarkers are the physiological and behavioral data collected by a body and can be quantified to be measured and analyzed through devices such as wearables, digestible, portables, and implantable. Biomarker discovery is an approach wherein experts from different fields collaborate and study the molecular structure of the body to understand and determine which specific molecular substances can be used to indicate the condition of the body i.e. which body is healthy and which is infected by a disease.

The aim of biomarker discovery programs is to identify molecular structures, study them to develop screening tests that can help identify the presence of disease on infection in those molecules and finally develop precise diagnostics tests for commercial use and purpose. In the past couple of years, discovery of several novel biomarkers has enabled researchers to identify a variety of cardiovascular events well in advance. There are different types of biomarkers, including diagnostic biomarkers and predictive biomarkers.

The role of diagnostic biomarkers is to accurately detect the disease. It helps in detecting cancer in a body through noninvasive ways and also supports secondary prevention of cancer. On the other hand, predictive biomarker predicts how a patient is likely to respond to a specific therapy being used for managing cancer. In addition, there is another type of biomarker known as prognostic. These biomarkers provide the clinical characteristics of the disease along with the possible path that the disease will take.

In the near future, the market for digital biomarkers is projected to increase. This growth is dependent on factors including explosion of wearable devices and increasing smartphone penetration, and increasing cost of drug development, among others. Based on the market research report published by BIS Research, “Global Digital Biomarkers Market - Analysis and Forecast, 2019-2025”, the digital biomarkers market is projected to grow at a CAGR of 40.39% during the forecast period from 2019 to 2025.

The digital biomarker market has been segmented on the basis of mode of data collection, applications, end-users, and region. North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World (ROW) are the major regional segments of the market. In 2018, the region of Asia-pacific was the major contributor to the digital biomarker market and is expected to maintain its dominance throughout the forecast period.

Comments

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...

Strategies Incorporated to Sustain the Competition

  The strategies followed by various prominent companies to sustain the competition and expand their market share has been varying from mergers and acquisitions (M&A) to collaborations and partnerships. In the past three years (January 2017-September 2020), the market witnessed approximately eight M&A activities, seven partnerships, and alliances (collaborations, joint ventures, and other agreements), one business expansion, and four other developments. Among the different key developments, M&A activities constitute the dominant contributor’s strategies, followed by partnership and alliances. The global bioengineered skin substitutes market is dominated by juggernauts including AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering wide ranges of bioengineered skin substitute products in the market. Several companies are attempting to enter the market and sustain...

Increasing Adoption of Lidar in Construction Applications

  The construction industry is continuously growing and has been witnessing various technological innovations. The construction industry depicts high complexity, steep costs, and low toleration for error, that facilitate the adoption of laser scanning. Lidars have enabled the construction industry to gain 3D models of existing space and build digital plans on those real spaces. Digital collaboration frameworks such as building information modelling (BIM) deliver the value of the scans to every element of a construction team in formats that are best suited to their needs. BIM schematics also provide continuing value to facility maintenance and operation teams. BIS Research Report on Lidar Market Numerous stages of construction projects are scanned for quality assurance, cross-checking with models, and spotting errors. Lidars can also be deployed for quality evaluation of prefabricated materials, allowing an efficient, and cheap evaluation. Furthermore, lidars find applications i...